iTolerance

Directions Website Contact the business

iTolerance is a privately held regenerative medicine company enabling tissue, organoid or cell therapy without the need for life-long immunosuppression.

10/08/2026

On , we recognize the potential of stem cell research to transform medicine.

iTolerance’s lead program leverages stem cell-derived pancreatic islets as a potentially inexhaustible supply of insulin-producing cells for Type 1 Diabetes.

10/06/2026

What’s next at iTolerance?

Be among the first to know about company milestones, pipeline progress and the latest developments from our team by signing up for email alerts.

Sign up: https://bit.ly/3PYFAqw

09/28/2026

Follow iTolerance’s progress beyond the feed.

Subscribe to our email alerts for direct access to company announcements, pipeline progress and important updates as we continue advancing our work.

Sign up: https://bit.ly/3PYFAqw

09/10/2026

For 100,000–135,000 people living with severe, uncontrolled “brittle” Type 1 Diabetes, managing blood sugar can mean facing unpredictable highs and dangerous lows.

iTolerance is working toward a future where treatment can offer more.

08/28/2026

At iTolerance, we're advancing data-driven regenerative medicine with the goal of enabling tissue, organoid and cell therapies without the need for lifelong immunosuppression.

08/17/2026

8.75 million people worldwide live with Type 1 Diabetes, yet many continue to face significant challenges despite insulin therapy.

iTolerance is advancing innovative approaches with the goal of transforming treatment.

08/07/2026

Be part of the journey.

Subscribe to iTolerance's email alerts for the latest updates as we work to advance innovative therapies for patients with type 1 diabetes.

Sign up: https://bit.ly/3PYFAqw

07/29/2026

An estimated 100K–135K people live with brittle Type 1 Diabetes, a severe form of the disease marked by dangerous blood sugar swings that can lead to seizures, coma, heart attacks and even death.

The unmet need remains significant.

07/22/2026

Be the first to hear what’s next at iTolerance.

Subscribe for email alerts and stay informed on the latest milestones, scientific progress and company developments.

Sign up: https://bit.ly/3PYFAqw

07/13/2026

At iTolerance, our values guide everything we do, from integrity and accountability to respect and teamwork.

Together, we are committed to advancing innovation while working to improve patients’ lives.

Address

1951 NW 7th Avenue
Miami, FL
33136

Website

http://www.itolerance.com/

Alerts

Be the first to know and let us send you an email when iTolerance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to iTolerance:

Christina Archer Consulting

Want your business to be the top-listed business in Miami?